TITLE:
CPG 7909 Injection in Melanoma

CONDITION:
Carcinoma, Melanoma

INTERVENTION:
CPG 7909 Injection

SUMMARY:

      To determine the safety, tolerability and effects of CPG 7909 (the study drug) when given
      with chemotherapy to patients with melanoma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologically or cytologically confirmed melanoma that is metastatic.

          -  Measurable disease according to the RECIST criteria.

          -  Karnofsky Performance Status of > 70.

        Exclusion Criteria:

          -  Prior treatment with anti-neoplastic biologic or chemotherapy for recurrent or
             metastatic disease (except one course of adjuvant immunotherapy and/or adjuvant
             chemotherapy other than DTIC).

          -  Suspected or known CNS metastases.
      
